Our faculty at the Icahn Institute and Department of Genetics and Genomic Sciences, are our most important asset in making scientific breakthroughs a reality.

Carmen Argmann, PhD, Associate Professor of Genetics and Genomic Sciences, gives us an in-depth look into her teams work in inflammatory bowel disease and type 2 diabetes. The goals of her work are to define novel biological processes underlying a disease, and then create treatments from those findings.

свернуть